Related Experiment Video
Updated: Mar 17, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Childhood tuberculosis: clinical research needs
S M Graham1, R P Gie, H S Schaaf
1Malawi-Liverpool-Wellcome Trust Research Programme and Department of Paediatrics, College of Medicine, Blantyre, Malawi. sgraham@mlw.medcol.mw
Insights
Childhood tuberculosis (TB) is a neglected disease, especially in developing nations. Improved diagnostic capabilities are crucial for better childhood TB management and future research, including vaccine development.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Childhood tuberculosis (TB) is prevalent in developing countries and increasing in human immunodeficiency virus (HIV) endemic areas.
- Children with TB are often not infectious, leading to lower priority in resource-limited public health programs.
- Diagnosing pulmonary TB in young children presents significant challenges, contributing to its neglect despite causing considerable morbidity and mortality.
Purpose of the Study:
- To review current knowledge on the clinical management of childhood TB.
- To identify priority areas for future research in childhood TB.
Main Methods:
- This is a review article summarizing existing knowledge.
- It synthesizes information on clinical aspects and management strategies for childhood TB.
Main Results:
- Childhood TB is a significant health issue, particularly in resource-limited settings.
- There is a critical need for enhanced diagnostic capabilities for childhood TB.
- Further research is needed on risk factors (including HIV impact), treatment outcomes, and contact management.
Conclusions:
- Improved diagnosis is paramount for advancing childhood TB management and research.
- Understanding risk factors and optimizing treatment are essential for controlling childhood TB.
- Future research should focus on diagnostics, immunology for vaccine development, and operational aspects.
Abstract:
Childhood tuberculosis (TB) is common in the developing world, where over 90% of global TB cases occur, and has increased in human immunodeficiency virus (HIV) endemic regions. Most children with TB are not infectious, and so, from a public health perspective, are not afforded the same priority by TB control programmes as older age groups in settings of limited resources. In addition, the diagnosis of pulmonary TB is particularly difficult in young children. This has resulted in TB being a neglected disease in children, although it causes substantial morbidity and mortality. This review summarises the current knowledge of clinical aspects of childhood TB management, and aims to identify priority areas for future research. The most critical need is for improved capability to confirm diagnosis. This would lead to better management of childhood TB and would greatly enhance our ability to conduct meaningful research in many related areas, including immunological studies which could lead to a more effective vaccine. Also important are a better understanding of risk factors for infection and disease, including the impact of HIV, and operational research to improve treatment outcomes and management of well childhood contacts.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Clinical Trials
There are four phases in a clinical trial. A phase one...

